Category: HeartWare International Inc.Syndicate content

HeartWare gains on positive heart pump data

April 14, 2014 by Brad Perriello

Shares of HeartWare International gain after the medical device company reports positive results for a post-approval study of its HVAD implantable heart pump.

HeartWare gains on positive heart pump data

HeartWare International (NSDQ:HTWR) shares are up today on the medical device company's 1st release of data since its HVAD implantable heart pump went on the U.S. market.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare slides on Q4, 2013 misses

February 27, 2014 by Brad Perriello

HeartWare shares come under pressure after the medical device company reports higher-than-expected losses for the 4th quarter and 2013.

HeartWare slides on Q4, 2013 misses

Investors punished HeartWare International (NSDQ:HTWR) today for missing expectations with its 4th-quarter and full-year results, paring some 3% from HTWR shares.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare slides on missed Q4 prelims

January 15, 2014 by Brad Perriello

HeartWare International's 4th-quarter preliminary sales numbers miss the mark on Wall Street, prompting investors to send its share price down.

HeartWare slides on missed Q4 prelims

HeartWare International (NSDQ:HTWR) said it expects to report 4th-quarter revenues of roughly $53 million, missing the consensus view on Wall Street of $58 million and sending its share price down sharply in pre-market trading.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: HeartWare CEO Doug Godshall details $350M CircuLite buyout

December 2, 2013 by Brad Perriello

HeartWare CEO Doug Godshall tells MassDevice.com about the 6-year journey to the $350 million acquisition of heart pump maker CircuLite.

UPDATE: HeartWare CEO Doug Godshall details $350M CircuLite buyout
UPDATE: HeartWare CEO Doug Godshall details $350M CircuLite buyout

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare buys CircuLite for up to $350M

December 2, 2013 by Brad Perriello

HeartWare International acquires CircuLite in a cash-and-stock deal that could eventually be worth up to $350 million.

HeartWare buys CircuLite for up to $350M
HeartWare buys CircuLite for up to $350M

Thoratec slides after NEJM reports increased blood clot rates

December 2, 2013 by Brad Perriello

Shares of Thoratec Corp. slide after the New England Journal of Medicine publishes results showing a sharp increase in rates of blood clots in patients implanted with the medical device company's HeartMate II left ventricular assist device.

Thoratec slides after NEJM reports increased blood clot rates

Thoratec (NSDQ:THOR) shares are under pressure after a New England Journal of Medicine study showing a sharp increase in the rate of thrombosis, or blood clots, in patients implanted with its HeartMate II left ventricular assist device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp